Maxim downgraded Gilead (GILD) to Hold from Buy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Early notable gainers among liquid option names on November 7th
- Gilead to present HIV research findings at conference
- Gilead price target raised to $80 from $70 at Cantor Fitzgerald
- Gilead price target raised to $105 from $95 at Oppenheimer
- Gilead price target raised to $105 from $95 at Piper Sandler